{Reference Type}: Journal Article
{Title}: Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth.
{Author}: Frappaolo A;Giansanti MG;
{Journal}: Cells
{Volume}: 12
{Issue}: 22
{Year}: 2023 11 14
{Factor}: 7.666
{DOI}: 10.3390/cells12222622
{Abstract}: The evolutionarily conserved target of rapamycin (TOR) serine/threonine kinase controls eukaryotic cell growth, metabolism and survival by integrating signals from the nutritional status and growth factors. TOR is the catalytic subunit of two distinct functional multiprotein complexes termed mTORC1 (mechanistic target of rapamycin complex 1) and mTORC2, which phosphorylate a different set of substrates and display different physiological functions. Dysregulation of TOR signaling has been involved in the development and progression of several disease states including cancer and diabetes. Here, we highlight how genetic and biochemical studies in the model system Drosophila melanogaster have been crucial to identify the mTORC1 and mTORC2 signaling components and to dissect their function in cellular growth, in strict coordination with insulin signaling. In addition, we review new findings that involve Drosophila Golgi phosphoprotein 3 in regulating organ growth via Rheb-mediated activation of mTORC1 in line with an emerging role for the Golgi as a major hub for mTORC1 signaling.